Back to
Boston Trust Walden CorpHAHAE
HAHAE30 quarters
Position history for
Boston Trust Walden Corp's holdings in HAEMONETICS CORP MASS
Boston Trust Walden Corp holds 585,148 shares of HAE (HAEMONETICS CORP MASS), worth $43.9M as of 2026-Q2. The position was increased (+16.6% shares). HAE represents 0.3% of Boston Trust Walden Corp's portfolio.
Current Value
$43.9M
Current Shares
585,148
Total Value Change
+$33.4M
Total Shares Change
+465,556
Quarter-by-Quarter History
Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS